Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease

medRxiv(2020)10.1101/2020.12.14.20248176Source: DataRank Database

Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0.561. It has been cited 41 times.

N/A

0.561DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (25)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.561

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (59)

Jack A. Kosmicki,Amy Damask ORCID,Deepika Sharma ORCID,Genevieve H. L. Roberts ORCID,Anne E. Justice ORCID

Live enrichment

PubMed:33619501 OpenAlex:https://openalex.org/W3112994972

National Institutes of Health

Grant: 3UL1TR001878-06S1

Institutional Clinical and Translational Science Award

greenLicense: cc-by-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/06/10/2020.12.14.20248176.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.12.14.20248176

repositoryhttps://doi.org/10.1101/2020.12.14.20248176

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33619501

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPARP inhibition in cancer therapy0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Coronavirus disease 2019 (COVID-19)Odds ratioDiseaseGenome-wide association studyGeneticsBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Angiotensin-converting enzyme 2GenomeGenetic variants2019-20 coronavirus outbreakGenotypeGeneInternal medicineMedicineSingle-nucleotide polymorphismVirologyInfectious disease (medical specialty)Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19

10.6084/m9.figshare.20356366.v1figshare

Additional file 1 of Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19

10.6084/m9.figshare.20356366figshare

Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease

FAIR Checklist

DataRank Breakdown

Authors (59)

Funding (1 grants)

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)